Skip to content

Kinesiotaping in Isolated Meniscus Injuries

The Effect of Kinesiotaping on Pain and Functionality in Isolated Meniscus Injuries: A Randomized Controlled Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07574307
Enrollment
75
Registered
2026-05-07
Start date
2026-04-01
Completion date
2026-10-30
Last updated
2026-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kinesio Taping, Meniscus Injury

Keywords

meniscus, knee injuries, pain, functional status, kinesio taping

Brief summary

The effect of kinesiotaping on pain and functionality in isolated meniscus injuries.

Detailed description

Our study was designed as a randomized controlled trial. All patients presenting to the Physical Medicine and Rehabilitation outpatient clinic with knee pain and meeting the inclusion criteria will be included in the study after being informed and giving their consent. Patients' age, gender, and body mass index will be recorded. Patients will be divided into three groups using stratified randomization. An attempt will be made to ensure a homogeneous distribution of patients in terms of gender, age, and body mass index. Group 1 will receive standard treatment, Group 2 will receive standard treatment + kinesiotaping, and Group 3 will receive standard treatment + sham taping. Standard treatment will consist of strengthening exercises for the quadriceps and hamstring muscles, stretching exercises around the knee, proprioceptive exercises, and activity modification. These exercises will be taught to the patient and they will be asked to perform them at home five days a week for three weeks. Kinesiotaping and sham taping will be applied three times, once every five days. Kinesiotaping will be applied to the group with a specific tension and technique (quadriceps facilitation technique, "Y" tape shape, applied with 25-50% tension), while the sham group will have the tape simply applied to the skin without any tension (perpendicular to the quadriceps muscle, tension-free). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%). All patients will have VAS and WOMAC parameters evaluated before treatment, on day 20, and at month 3 after treatment.

Interventions

PROCEDUREsham taping

sham taping will be applied three times, once every five days. the sham group will have the tape simply applied to the skin without any tension (perpendicular to the quadriceps muscle, tension-free). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).

BEHAVIORALExercise

rengthening exercises for the quadriceps and hamstring muscles, stretching exercises around the knee, proprioceptive exercises, and activity modification.

PROCEDUREkinesiotaping

Kinesiotaping will be applied three times, once every five days. Kinesiotaping will be applied to the group with a specific tension and technique (quadriceps facilitation technique, "Y" tape shape, applied with 25-50% tension). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).

Sponsors

Bandırma Onyedi Eylül University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Patients included in the study will be divided into 3 groups: Group 1 will receive exercise in addition to standard treatment, Group 2 will receive kinesiotaping in addition to standard treatment, and Group 3 will receive sham taping in addition to standard treatment.

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Ages 18-50 * Knee pain lasting longer than 2 weeks * Having a diagnosis of isolated meniscus injury (grade 1, 2 or 3 meniscus degeneration) confirmed by magnetic resonance imaging (MRI) * Not having undergone knee surgery in the last 6 months * Not having received intraarticular injections in the knee area * Being willing to participate in the study

Exclusion criteria

* Trauma history * Anterior or posterior cruciate ligament injury * Collateral ligament injuries * Advanced knee osteoarthritis * Rheumatic or neurological disease * Allergy or skin condition to kinesiotape * History of intraarticular injection * Neuromuscular dysfunction * Rheumatological disease * Cognitive dysfunction

Design outcomes

Primary

MeasureTime frameDescription
WOMAC3 monthsThe Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a widely used, valid, and reliable index for evaluating patients with osteoarthritis. It is also very commonly used in knee problems other than osteoarthritis to assess knee pain and knee function. It is a recommended metric for osteoarthritis studies by the Outcome Measures in Rheumatology Clinical Trials (OMERACT). The WOMAC OA index, validated and proven reliable in Turkish by Tüzün et al., consists of three sections and 24 questions assessing pain, stiffness, and physical function. The maximum possible scores are 20 for the pain subgroup, 8 for stiffness, and 68 for physical function. Higher scores indicate increased pain and stiffness, and impaired physical function.
VAS3 monthsThe VAS (Visual Analog Scale) will be used to determine the severity of knee pain. The VAS is a reliable and easily applicable scale accepted worldwide in the literature for measuring the severity of pain in patients. The Visual Analog Scale is used to convert values that cannot be measured numerically into numerical values. It is a scale where the starting point is -0- "no pain" and the other end is -10- "very severe pain," with numerical values assigned to each centimeter (cm) in one-centimeter increments.

Countries

Turkey (Türkiye)

Contacts

CONTACTNurten NAS KIRDAR, Assistant Professor
nkirdar@bandirma.edu.tr+905415511691
PRINCIPAL_INVESTIGATORNurten NAS KIRDAR, Assistant Professor

Bandırma Onyedi Eylül University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 8, 2026